Dr. Haberman will also moderate
panels and chair sessions on the above and related topics.
He and his associates will also run
interactive seminars at your company designed to help you to meet key
challenges in technology strategy, product development and business development
in the life sciences.
Biographical
Information:
Allan B. Haberman, Ph.D. is Principal of Haberman Associates, a
consulting firm specializing in science and technology strategy for
pharmaceutical, biotechnology, and other life science companies. He is also a
Principal and Founder of the Biopharmaceutical Consortium, an expert team
formed to assist life science companies, research groups, and emerging
enterprises to identify and exploit promising breakthrough technologies.
Dr. Haberman speaks at national and international
conferences on the pharmaceutical/biotechnology industry and on drug discovery
and development.
His consulting activities include work in new product
development and technology strategy, opportunity assessment, assessment of drug
pipelines, and due diligence on established and emerging biotechnology
companies. Dr. Haberman is also the author of numerous publications on the
pharmaceutical and biotechnology industries, their technologies and products,
and on the major therapeutic areas for drug discovery and development. He
received his Ph.D. in biochemistry and molecular biology from Harvard
University.
